Although it does not promote GR dimerization and transactivation, it retains anti-inflammatory potential by repressing the NF-κB signaling pathway, without inducing the expression of skin atrophy markers, when topically applied in in vitro and in vivo mouse models [39,56]. This evidence concerns the gene NFKB1 and skin atrophy.